FDA approves inhalable diabetes drug Afrezza
Regulations » After three years, MannKind Corp. gets OK for fast-acting form of insulin.
The Associated Press
First Published Jun 27 2014 02:32 pm • Last Updated Jun 27 2014 02:32 pm
Reader comments on sltrib.com are the opinions of the writer, not The Salt Lake Tribune. We will delete comments containing obscenities, personal attacks and inappropriate or offensive remarks. Flagrant or repeat violators will be banned. If you see an objectionable comment, please alert us by clicking the arrow on the upper right side of the comment and selecting "Flag comment as inappropriate". If you've recently registered with Disqus or aren't seeing your comments immediately, you may need to verify your email address. To do so, visit disqus.com/account
. See more about comments here.